LVI Status Was Associated with Worse Prognosis in PDAC Survival analysis revealed that, although it did not reach statistical significance, patients with positive LVI tumors tended to have a shorter median disease-free survival (DFS) compared with patients without LVI (median DFS time: 12.2 vs. 20.4 months, p = 0.069, Figure 2 A).
← all excerpts
Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.
1
—
—